| Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity ML Choi, A Chappard, BP Singh, C Maclachlan, M Rodrigues, ... Nature neuroscience 25 (9), 1134-1148, 2022 | 119 | 2022 |
| The impact of type 2 diabetes in Parkinson's disease D Athauda, J Evans, A Wernick, G Virdi, ML Choi, M Lawton, ... Movement Disorders 37 (8), 1612-1623, 2022 | 51 | 2022 |
| Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s CE Toomey, WE Heywood, JR Evans, J Lachica, SN Pressey, SC Foti, ... Acta neuropathologica communications 10 (1), 134, 2022 | 37 | 2022 |
| Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons GS Virdi, ML Choi, JR Evans, Z Yao, D Athauda, S Strohbuecker, ... npj Parkinson's Disease 8 (1), 162, 2022 | 25 | 2022 |
| Stress reactivity elicits a tissue-specific reduction in telomere length in aging zebrafish (Danio rerio) JR Evans, JV Torres-Pérez, ME Miletto Petrazzini, R Riley, CH Brennan Scientific Reports 11 (1), 339, 2021 | 15 | 2021 |
| Prediction of mechanistic subtypes of Parkinson’s using patient-derived stem cell models K D’Sa, JR Evans, GS Virdi, G Vecchi, A Adam, O Bertolli, J Fleming, ... Nature Machine Intelligence 5 (8), 933-946, 2023 | 6 | 2023 |
| The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1 EK Gustavsson, S Sethi, Y Gao, JW Brenton, S García-Ruiz, D Zhang, ... Science Advances 10 (26), eadk1296, 2024 | 1 | 2024 |
| Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson’s disease LG Devito, ZS Zanjani, JR Evans, A Scardamaglia, H Houlden, S Gandhi, ... Stem Cell Research 71, 103134, 2023 | | 2023 |
